Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Oct 15, 2006 (Vol. 26, No. 18)


  • Wealth of information
  • Confusing in places
If you’re looking for a cute metaphor, check out ProteomeCommons with its delicious looking chocolate cake on the opening page, the selected pieces titled News, Tools, Data, and More. The icing on the cake for this one is the text at the bottom proclaiming, “You can have your cake and eat it too.” While I’m not clear how the metaphor extends to the site itself, it certainly is an eye-catcher. ProteomeCommons is a public repository for proteomics digital content. The news feeds are impressive and up to date, though a bit chaotic in organization. Visitors can download data sets and open-source software relating mostly to mass spectrometry. While the idea for this site is solid and the pages provide much useful information, I must quibble with the overly simplistic scheme. A bit more attention to organization would be welcome.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »